Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viread vs Hepsera in HBeAg-negative chronic hepatitis B
NCT00117676Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2005
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Feb 2005; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00117676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117676.